Heliogen, Inc.
Heliogen, Inc. (HLGN) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Heliogen, Inc. (HLGN), covering cash flow, earnings, and balance sheets.
Heliogen, Inc. (HLGN) Income Statement & Financial Overview
View the income breakdown for Heliogen, Inc. HLGN across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $15.005M | $1.05M | $2.26M | $954000.00 |
| Cost of Revenue | -$72.60M | $1.11M | $3.93M | $1.48M |
| Gross Profit | $87.60M | -$60000.00 | -$1.67M | -$523000.00 |
| Gross Profit Ratio | $5.84 | -$0.06 | -$0.74 | -$0.55 |
| R&D Expenses | $3.28M | $4.51M | $4.75M | $3.79M |
| SG&A Expenses | $6.61M | $7.85M | $9.51M | $12.39M |
| Operating Expenses | $9.17M | $12.56M | $14.26M | $15.60M |
| Total Costs & Expenses | -$63.43M | $13.68M | $18.18M | $17.08M |
| Interest Income | $406000.00 | $535000.00 | $675000.00 | $683000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $63000.00 | $107000.00 | $349000.00 | $446000.00 |
| EBITDA | $81.16M | -$12.32M | -$16.12M | -$15.68M |
| EBITDA Ratio | $5.41 | -$11.73 | -$7.13 | -$16.44 |
| Operating Income | $78.43M | -$12.42M | -$15.92M | -$16.13M |
| Operating Income Ratio | $5.23 | -$11.83 | -$7.04 | -$16.90 |
| Other Income/Expenses (Net) | $439000.00 | $607000.00 | -$3.36M | $904000.00 |
| Income Before Tax | $78.87M | -$11.82M | -$19.28M | -$15.22M |
| Income Before Tax Ratio | $5.26 | -$11.25 | -$8.53 | -$15.96 |
| Income Tax Expense | $1000.00 | -$1000.00 | $2000.00 | $2000.00 |
| Net Income | $78.87M | -$11.81M | -$19.28M | -$15.22M |
| Net Income Ratio | $5.26 | -$11.25 | -$8.53 | -$15.96 |
| EPS | $12.86 | -$1.94 | -$3.19 | -$2.53 |
| Diluted EPS | $12.55 | -$1.94 | -$3.19 | -$2.53 |
| Weighted Avg Shares Outstanding | $6.13M | $6.09M | $6.05M | $6.02M |
| Weighted Avg Shares Outstanding (Diluted) | $6.28M | $6.09M | $6.05M | $6.02M |
Over the past four quarters, Heliogen, Inc. demonstrated steady revenue growth, increasing from $954000.00 in Q1 2024 to $15.005M in Q4 2024. Operating income reached $78.43M in Q4 2024, maintaining a consistent 523% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $81.16M, reflecting operational efficiency. Net income rose to $78.87M, with EPS at $12.86. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan